Clarivate Science Holdings Corp, founded in 2016 and headquartered in Philadelphia, provides expert insights and analytics that empower organizations to accelerate innovation. The company specializes in solutions that cater to the life sciences, academia, and intellectual property sectors, offering a range of products including the Web of Science platform and Cortellis drug research intelligence.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| CLVTSC 3.88% 2028-07-01 USDClarivate Science Holdings Corp | United States | 2028-07-01 | 3.875 | 5.65 |
| CLVTSC 3.88% 2028-07-01 USDClarivate Science Holdings Corp | United States | 2028-07-01 | 3.875 | 5.52 |
| CLVTSC 4.88% 2029-07-01 USDClarivate Science Holdings Corp | United States | 2029-07-01 | 4.875 | 7.04 |
| CLVTSC 4.88% 2029-07-01 USDClarivate Science Holdings Corp | United States | 2029-07-01 | 4.875 | 6.86 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Clarivate began issuing bonds to support its growth strategy, with its first bond issuance occurring in 2020. Notably, in 2021, the company secured $1 billion in senior notes to enhance liquidity and fund strategic acquisitions. Currently, Clarivate’s bonds yield competitively within the industry, reflecting strong investor confidence. Recent reports indicate that these bonds maintain attractive features, including call options, allowing for potential refinancing as market conditions evolve.